NCT03624192 - RES Prepared With RECELL® Compared to Conventional Care for Healing of Donor Sites in Ages 1-16 Years | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 19, 2018

Primary Completion Date

January 13, 2020

Study Completion Date

January 13, 2020

Conditions

Skin; Deformity

Interventions

DEVICE

RECELL® Autologous Cell Harvesting Device

Application of RES prepared using the RECELL® Autologous Cell Harvesting Device along with Telfa™ Clear primary and Xeroform™ secondary wound dressings

OTHER

Telfa™ Clear and Xeroform™ dressings

Trial Locations (7)

44308

Akron Children's Hospital, Akron

52242

University of Iowa Hospitals and Clinics, Iowa City

85008

Arizona Burn Center at Maricopa Intergrated Health Systems, Phoenix

92103

University of California at San Diego, San Diego

95817

Shriners Hospital for Children, Northern California, Sacramento

98104

University of Washington Regional Burn Center at Harborview Medical Center, Seattle

02114

Shriners Hospital for Children, Boston, Boston